Investigating reproducible plastisol cannula fabrication

研究可重复的塑料溶胶插管制造

• 批准号: 530500-2018
• 负责人: Dalton, Colin
• 金额: $ 1.82万
• 依托单位: University of Calgary
• 依托单位国家: 加拿大
• 项目类别: Engage Grants Program
• 财政年份: 2018
• 资助国家: 加拿大
• 起止时间: 2018-01-01 至 2019-12-31
• 项目状态: 已结题
• 来源: https://www.nserc-crsng.gc.ca/ase-oro/Details-Detailles_eng.asp?id=648551
• 关键词: Investigating; reproducible; plastisol; cannula; fabrication

Elsius Biomedical Corp. is a Canadian medical device company located in Calgary that is developing a portable Cardiopulmonary Assist System (pCAS). The technology is based on Extracorporeal membrane oxygenation (ECMO). ECMO is a complex lifesaving technology that provides circulatory and respiratory support to very sick patients who are experiencing certain kinds of circulatory or respiratory failure. It requires a cannula to be inserted into the patient's body, which reroutes blood out of the patient into the pCAS system and then back into the body (usually via the femoral or jugular veins). It is difficult for Elsius to source small quantities of cannulas for validation testing of pCAS technology.This study will aid Elsius in developing their own in-house cannula fabrication knowledge.

Elsius Biomedical Corp.是位于卡尔加里的一家加拿大医疗设备公司，正在开发便携式心肺辅助系统（PCAS）。该技术基于体外膜氧合（ECMO）。 ECMO是一项复杂的救生技术，可为经历某些类型的循环或呼吸衰竭的非常病的患者提供循环和呼吸支持。它要求将套管插入患者的身体，该套管将血液从患者中重新穿入PCAS系统，然后再回到体内（通常是通过股骨或颈静脉）。 Elsius很难为PCAS技术的验证测试提供少量的插管。这项研究将有助于Elsius开发自己的内部套管制造知识。